- Home
- EDSA vs MTEX Comparison
EDSA vs MTEX Comparison
Compare EDSA & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- MTEX
- Stock Information
- Founded
- EDSA 2015
- MTEX 1993
- Country
- EDSA Canada
- MTEX United States
- Employees
- EDSA N/A
- MTEX N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- MTEX Medicinal Chemicals and Botanical Products
- Sector
- EDSA Health Care
- MTEX Health Care
- Exchange
- EDSA Nasdaq
- MTEX Nasdaq
- Market Cap
- EDSA 13.8M
- MTEX 13.6M
- IPO Year
- EDSA N/A
- MTEX 1999
- Fundamental
- Price
- EDSA $4.06
- MTEX $7.50
- Analyst Decision
- EDSA Strong Buy
- MTEX
- Analyst Count
- EDSA 2
- MTEX 0
- Target Price
- EDSA $39.00
- MTEX N/A
- AVG Volume (30 Days)
- EDSA 12.3K
- MTEX 4.6K
- Earning Date
- EDSA 08-09-2024
- MTEX 11-05-2024
- Dividend Yield
- EDSA N/A
- MTEX N/A
- EPS Growth
- EDSA N/A
- MTEX N/A
- EPS
- EDSA N/A
- MTEX N/A
- Revenue
- EDSA N/A
- MTEX $122,380,000.00
- Revenue This Year
- EDSA N/A
- MTEX N/A
- Revenue Next Year
- EDSA N/A
- MTEX N/A
- P/E Ratio
- EDSA N/A
- MTEX N/A
- Revenue Growth
- EDSA N/A
- MTEX N/A
- 52 Week Low
- EDSA $2.50
- MTEX $6.75
- 52 Week High
- EDSA $8.33
- MTEX $10.51
- Technical
- Relative Strength Index (RSI)
- EDSA 42.54
- MTEX 50.05
- Support Level
- EDSA $4.13
- MTEX $7.30
- Resistance Level
- EDSA $4.44
- MTEX $7.96
- Average True Range (ATR)
- EDSA 0.22
- MTEX 0.17
- MACD
- EDSA -0.01
- MTEX -0.02
- Stochastic Oscillator
- EDSA 6.90
- MTEX 47.87
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.